We recently compiled a list of the 7 Best Medical Technology Stocks To Buy According To Analysts. In this article, we are ...

Earnings Call Insights: Bio-Rad Laboratories (NYSE:BIO) Q4 2024 Chief Operating Officer Jon DiVincenzo stated that Bio-Rad met its revised 2024 guidance for revenue and operating margin ...

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through ...

Tech and life sciences companies have slashed hundreds more Bay Area jobs, affecting workers in the South Bay, East Bay and San Francisco, marking a fresh round of employment setbacks for the vital ...

Equities researchers at Zacks Research reduced their Q1 2025 EPS estimates for shares of Bio-Rad Laboratories in a research ...

Bio-Rad Laboratories, Inc. has a 52-week low of $244.00 and a 52-week high of $387.99. The stock’s fifty day simple moving average is $315.10 and its 200-day simple moving average is $328.93.

HERCULES, Calif. — 10 March Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics ...

Key Insights Significantly high institutional ownership implies Bio-Rad Laboratories' stock price is sensitive to ...

Biomarker Research Services Market is estimated to be valued at USD 10.98 Bn in 2025 and is expected to reach USD 310.66 Bn by 2032, exhibiting a CAGR of 61%. Mr. Shah Coherent Market Insights Pvt.

Bio-Rad Laboratories, Inc, a leading provider of life science research and clinical diagnostics solutions, has unveiled the ...